Click for the Mectizan Home page
About MDP   Onchocerciasis   Lymphatic Filariasis   MDP News   Mectizan Expert Committee (MEC) News

Introduction | Lifecycle | Distribution / Map* | Treatment Loiasis

Distribution of Onchocerciasis Worldwide

Onchocerciasis is endemic in 28 African countries, one country in the Middle East, and six countries in Latin America. More than 99% of all cases of onchocerciasis and onchocerciasis-related blindness in the world are found on the African continent.1 The distribution of onchocerciasis in the Middle East and Latin America is focal. In these two regions, the burden of disease represents less than 1% of the global problem; however onchocerciasis remains a significant cause of morbidity. 



The 26 countries in Africa where mass treatment with Mectizan is indicated and ongoing for onchocerciasis, as of the end of 2005. Countries are color coded according to their inclusion in the former OCP (green) or APOC (yellow) regions. As of the end  of 2005, there were mass treatment programs with Mectizan for onchocerciasis in all 26 African countries where such intervention is epidemiologically justified. These 26 countries, plus Niger and Mozambique, are eligible for Mectizan combined with albendazole for national programs to eliminate Lymphatic Filariasis. This map is reproduced with permission of the Annals of Tropical Medicine and Parasitology, 2006, Volume 100, pages 733-46.




Foci in Latin America (OEPA region) where onchocerciasis is endemic and where mass treatment with Mectizan is indicated and ongoing, as of the end of 2005. In Latin America (OEPA region), as of the end of 2005, all onchocerciasis endemic foci were indicated for twice-yearly mass treatment with Mectizan, regardless of endemicity, as a strategy for the elimination of onchocercal morbidity and transmission of infection. This map is reproduced with permission of the Annals of Tropical Medicine and Parasitology, 2006, Volume 100, pages 733–46.

Distribution of Onchocerciasis and Lymphatic Filariasis in Africa

In Africa, 40 countries are believed to be endemic for lymphatic filariasis.2 The extent of overlap between LF and onchocerciasis within these African countries is currently unknown.

References

1. World Health Organization. Onchocerciasis and its control, report of a WHO Expert Committee on Onchocerciasis Control. Geneva: World Health Organization; 1995. Technical Report Series No.: 852.

2. World Health Organization. Lymphatic filariasis. Wkly Epidemiol Rec 2001;76(20): 149-154.



SIGN UP FOR OUR NEWSLETTER
Program
Information
History & Background

Onchocerciasis

Onchocerciasis treatments approved

Lymphatic Filariasis

Lymphatic Filariasis  treatments approved

Mass Treatment

Humanitarian Program / Special requests for Mectizan

How to Apply/
Review Process


Technical Requirements

Program Partners

MDP Brochures

NEW! Drug Management




Mectizan Donation
Program News
NEW! Operational lessons from 20 years of the Mectizan Donation Program for the control of onchocerciasis

NEW! 2007 MDP Annual Highlights

NEW! Article on drug donations for NTDs in Nature

NEW!
"The Mectizan Donation Program—Highlights from 2005" published in the Filaria Journal (PDF)

"Towards the Elimination of Onchocerciasis" published in the Annals of Tropical Medicine and Parasitology (PDF)


Studies on the impact of MDP

MDP NEWSLETTER: current and archives

Mectizan Expert Committee News

News from the Mectizan Expert Committee / Albendazole Coordination Meetings

Recommendations for the treatment of onchocerciasis with Mectizan in areas co-endemic for onchocerciasis and loiasis

Merck Mectizan Award Winners

 
 
site map | advanced 
 Contact

Mectizan® Donation Program (MDP)
325 Swanton Way
Decatur, Georgia 30030
USA
P: +1 (404) 371-1460
F: +1 (404) 371-1138
Contact Us

To sign up for our newsletter please email mectizan@taskforce.org
Program Information   Onchocerciasis   Lymphatic Filariasis
MDP News   Mectizan Expert Committee News   Contact Us   Site Map
© 2008 Mectizan Donation Program. All Rights Reserved. Admin